AAN2013:抑郁可升高卒中患者死亡风险

2013-01-14 AAN2013 CMT 高晓方 编译

Table. Adjusted Risk for All-Cause and Stroke Mortality With Stroke and Depression vs Neither Condition   即将于第65届美国神经病学学会(AAN2013)年会公布的一项报告表明,同时伴抑郁和卒中的患者全因死亡风险升高;治疗抑郁有可能改善此类患者的临床转归。   此项研究从美国健康和营养


Table. Adjusted Risk for All-Cause and Stroke Mortality With Stroke and Depression vs Neither Condition

  即将于第65届美国神经病学学会(AAN2013)年会公布的一项报告表明,同时伴抑郁和卒中的患者全因死亡风险升高;治疗抑郁有可能改善此类患者的临床转归。

  此项研究从美国健康和营养调查I(NHANES I)流行病学随访研究中纳入10,550例受试者。受试者年龄为25~75岁,随访时间为21年。发生卒中但无抑郁、同时伴卒中和抑郁、无卒中和抑郁、伴抑郁但无卒中的受试者分别为73、48、8138和2291例。以流行病调查中心抑郁量表评分≥16分定义抑郁。对结果进行人口统计学(年龄你给、性别和种族)和社会经济(教育程度、收入水平和婚姻状况)因素校正。

  结果显示,在未校正分析中,同时伴卒中和抑郁的受试者全因死亡风险升高4倍以上。对社会人口统计因素进行校正之后,上述受试者的全因死亡风险仍升高近3倍(危险比[HR] 2.86)。与无卒中和抑郁的受试者相比,同时伴上述两种疾病的受试者卒中死亡风险亦升高近4倍(HR 3.69)。行为改变可能为抑郁与卒中患者死亡率升高的联系机制。

  原文阅读:Depression Linked to Increased Stroke Mortality




    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719994, encodeId=36271e1999407, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Feb 13 10:56:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983403, encodeId=8f5a19834030f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 09 20:56:00 CST 2013, time=2013-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255429, encodeId=76d812554293d, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446409, encodeId=f9ed144640942, content=<a href='/topic/show?id=2e3016e437' target=_blank style='color:#2F92EE;'>#AAN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1674, encryptionId=2e3016e437, topicName=AAN)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIt6X4iaHW8bDticcBSHUibNWk4Koe2icf0pdIOicSueicR3AKmviaSNPHkf9bCEicRK0anXEu3DjolU2EmkQ/132, createdBy=98ca5217513, createdName=bluefate123, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719994, encodeId=36271e1999407, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Feb 13 10:56:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983403, encodeId=8f5a19834030f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 09 20:56:00 CST 2013, time=2013-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255429, encodeId=76d812554293d, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446409, encodeId=f9ed144640942, content=<a href='/topic/show?id=2e3016e437' target=_blank style='color:#2F92EE;'>#AAN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1674, encryptionId=2e3016e437, topicName=AAN)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIt6X4iaHW8bDticcBSHUibNWk4Koe2icf0pdIOicSueicR3AKmviaSNPHkf9bCEicRK0anXEu3DjolU2EmkQ/132, createdBy=98ca5217513, createdName=bluefate123, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719994, encodeId=36271e1999407, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Feb 13 10:56:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983403, encodeId=8f5a19834030f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 09 20:56:00 CST 2013, time=2013-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255429, encodeId=76d812554293d, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446409, encodeId=f9ed144640942, content=<a href='/topic/show?id=2e3016e437' target=_blank style='color:#2F92EE;'>#AAN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1674, encryptionId=2e3016e437, topicName=AAN)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIt6X4iaHW8bDticcBSHUibNWk4Koe2icf0pdIOicSueicR3AKmviaSNPHkf9bCEicRK0anXEu3DjolU2EmkQ/132, createdBy=98ca5217513, createdName=bluefate123, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719994, encodeId=36271e1999407, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Wed Feb 13 10:56:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983403, encodeId=8f5a19834030f, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 09 20:56:00 CST 2013, time=2013-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255429, encodeId=76d812554293d, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446409, encodeId=f9ed144640942, content=<a href='/topic/show?id=2e3016e437' target=_blank style='color:#2F92EE;'>#AAN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1674, encryptionId=2e3016e437, topicName=AAN)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIt6X4iaHW8bDticcBSHUibNWk4Koe2icf0pdIOicSueicR3AKmviaSNPHkf9bCEicRK0anXEu3DjolU2EmkQ/132, createdBy=98ca5217513, createdName=bluefate123, createdTime=Wed Jan 16 01:56:00 CST 2013, time=2013-01-16, status=1, ipAttribution=)]
    2013-01-16 bluefate123

相关资讯

六成心脏病人抑郁增加死亡风险

  美国哥伦比亚大学医学中心发布的一项调查显示,出现过一次心脏病发作的人群中,约1/8表现出创伤后应激障碍(PTSD)的症状。与没有心理障碍的心脏病人相比,他们在1-3年内再次遭遇心脏病发作的风险大大增加。这提示我们,突发心脏病患者的心理危机干预亟待关注。   我国心脏病人罹患心理障碍者并不少见。根据我院的一项调查显示,在心脏病发作后,至少1/10的患者会出现不同程度的焦虑、抑郁与适应障碍等症状

Am J Cardiol:肥胖为高敏C反应蛋白升高重要预测因素

  美国学者的一项研究表明,肥胖为高敏C反应蛋白(hs-CRP)升高的最重要预测因素。论文于2012年11月5日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究从前瞻性人群中纳入289例患者。对多种潜在预测因素与hs-CRP的相关性进行评估。对潜在混淆因素进行校正之后,利用双变量和多变量线性回归模型对肥胖、体育活动、抑郁及其他数种潜在因素进行分析。

PLoS One:卒中后抑郁患者卒中复发风险增加

  首都医科大学附属北京天坛医院王拥军教授等报告,在我国住院卒中患者中,近三成在卒中发作2 周内诊断为卒中后抑郁(PSD);PSD 患者卒中复发风险为无PSD 患者的1.49 倍。   在我国,卒中已超过冠心病,成为成年人首位死因。尽管诊治技术的进步极大地改善了卒中的预防和治疗,但卒中复发仍是需要关注的问题。有研究显示,我国卒中患者中卒中复发率高达16%。

DIABETES RES CLIN PR:糖尿病显著增加抑郁风险

  意大利的一项荟萃研究提示,糖尿病与抑郁风险显著增加相关。文章认为糖尿病与抑郁症相关的病理机制值得进一步探讨。相关论文2012年12月26日在线发表于《糖尿病研究与临床实践》杂志(Diabetes Research and Clinical Practice)。   该荟萃研究使用关键词“糖尿病和抑郁或糖尿病和抗抑郁药”检索Medline,选择那些

Biol Psychiatry:实验药物有望‘在数分钟内’帮助治疗抑郁

       12月3日在线发表于《生物精神病学》的新研究表明,尽管一种被描述为“友好版氯胺酮”的新型实验药物似乎可快速减少抑郁症状,但其效应可能不会长期持续存在。        由国立精神卫生研究所(NIMH)的研究者进行的一项小型随机交叉研究显示,单次滴注AZD6765后,近32%的难治性重性抑郁障碍

AM J GERIAT PSYCHIAT:抑郁与痴呆相关再添新证

       一项新的研究表明,严重的抑郁症状可预测老年患者人群将来发生轻度认知功能障碍(MCI),甚至是痴呆。这项研究发表在最近的《美国老年精神病学》杂志上。          这项纳入300多名年龄85岁及以上的女性的前瞻性研究表明,基线时抑郁评分较高的患者与抑郁评分较低患者相比,在5年之内发生MC